Michael Højby Rasmussen — Georgetown University

Area of research

Endocrinology, Diabetes and Metabolism · Physiology

Research interest

Research interests include Medicine, Internal medicine, Pediatrics, Endocrinology, Randomized controlled trial, and Tolerability.

Recent publications

Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3

The Journal of Clinical Endocrinology & Metabolism 2023cited by 32position: middledoi

Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3

The Journal of Clinical Endocrinology & Metabolism 2021cited by 49position: middledoi

Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial

The Journal of Clinical Endocrinology & Metabolism 2020cited by 61position: middledoi

Somapacitan, a once‐weekly reversible albumin‐binding <scp>GH</scp> derivative, in children with <scp>GH</scp> deficiency: A randomized dose‐escalation trial

Clinical Endocrinology 2017cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tadej Battelino · University of Adelaide3 papers (2017–2023)Lars Sävendahl · Karolinska University Hospital3 papers (2017–2023)— · 2 papers (2021–2023)— · 2 papers (2021–2023)— · 2 papers (2021–2023)Jean De Schepper · Gene Therapy Laboratory1 papers (2017–2017)Zoran Gucev · Children's Clinical University Hospital1 papers (2017–2017)— · 1 papers (2023–2023)— · 1 papers (2017–2017)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Endocrinology, Diabetes and Metabolism · Physiology →